Literature DB >> 8888720

Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer.

R J Brummer1, R W Stockbrügger.   

Abstract

The study investigated the effect of either nocturnal acid suppression by the H2 antagonist nizatidine 300 mg at night or prolonged acid suppression by the proton- pump inhibitor omeprazole 20 mg in the morning, during four weeks, on intragastric pH profile, occurrence of bacterial growth in gastric fluid and biopsies, and healing rate in 23 patients with an acute duodenal ulcer. The endoscopic healing rate did not differ significantly between the two treatment modalities. The 24-hr acid secretion was significantly more reduced by omeprazole than nizatidine (P < 0.002). After treatment by nizatidine and omeprazole, respectively, median 24-hr intragastric pH increased from 1.5 to 1.8 (P < 0.01) and from 1.5 to 6.1 (P < 0.01), respectively. Nighttime acid inhibition did not differ significantly. The difference in gastric bacterial colonization after either omeprazole or nizatidine did not reach significance. However, median 24-hr pH and the fraction of the day with pH < 3 and pH < 4 were significantly correlated to bacterial colonization of the gastric fluid (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888720     DOI: 10.1007/bf02093609

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  Twenty-four-hour intragastric acidity: 300 mg ranitidine b.d., 20 mg omeprazole o.m., 40 mg omeprazole o.m. vs. placebo.

Authors:  G M Houben; J Hooi; W Hameeteman; R W Stockbrügger
Journal:  Aliment Pharmacol Ther       Date:  1995-12       Impact factor: 8.171

2.  Day-to-day variation of 24-hour intragastric acidity.

Authors:  H S Merki; L Witzel; R P Walt; E Cohnen; K Harre; J Heim; A Mappes; J Röhmel
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

3.  Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.

Authors:  D B Jones; C W Howden; D W Burget; G D Kerr; R H Hunt
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

4.  Effect of cimetidine and antacid on gastric microbial flora.

Authors:  R Snepar; G A Poporad; J M Romano; W D Kobasa; D Kaye
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

5.  Duodenal bacterial overgrowth during treatment in outpatients with omeprazole.

Authors:  M Fried; H Siegrist; R Frei; F Froehlich; P Duroux; J Thorens; A Blum; J Bille; J J Gonvers; K Gyr
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

6.  Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.

Authors:  E Verdu; F Viani; D Armstrong; R Fraser; H H Siegrist; B Pignatelli; J P Idström; C Cederberg; A L Blum; M Fried
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

7.  Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.

Authors:  B Hallerbäck; P Unge; L Carling; B Edwin; H Glise; N Havu; E Lyrenäs; K Lundberg
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

Review 8.  Bacteria in the aetio-pathogenesis of gastric cancer: a review.

Authors:  G M Houben; R W Stockbrügger
Journal:  Scand J Gastroenterol Suppl       Date:  1995

9.  Mutagens, N-nitroso compounds and their precursors in gastric juice from patients with and without precancerous lesions of the stomach.

Authors:  B Pignatelli; C Malaveille; A Rogatko; A Hautefeuille; P Thuillier; N Muñoz; B Moulinier; F Berger; H De Montclos; R Lambert
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

10.  Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.

Authors:  I Hamilton; B W Worsley; H J O'Connor; A T Axon
Journal:  Gut       Date:  1983-12       Impact factor: 23.059

View more
  2 in total

1.  Bacterial flora concurrent with Helicobacter pylori in the stomach of patients with upper gastrointestinal diseases.

Authors:  Yuan Hu; Li-Hua He; Di Xiao; Guo-Dong Liu; Yi-Xin Gu; Xiao-Xia Tao; Jian-Zhong Zhang
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

2.  Colonization by Pseudomonas aeruginosa and Staphylococcus aureus of Antral Biopsy Specimens from Gastritis Patients Uninfected with Helicobacter Pylori.

Authors:  Vida Kachuei; Amin Talebi Bezmin Abadi; Farid Rahimi; Mojgan Forootan
Journal:  Infect Drug Resist       Date:  2020-05-13       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.